| Home Market Dynamics You and Market Sector Analysis Company Insights AI Investing About Contact Us Login |
| The price action of Biotechnology (IBB) sector is shaped by numerous forces, ranging from broad macroeconomic trends to company-specific performance and market structure. The overall sentiment for Biotechnology sector is very positive (overall 3, positive 3.3, negative -0.3) on 20251117. The forces of Price Level (2), Option Speculation (1.5), Sector Price Trend (1.2), Sentiment towards Fundamentals (1), Valuation Sentiment (0.8), and Broad Market Trend (-0.5) will drive up the price. The forces of and Market Risk Prefrence (0) will drive down the price. 'Buy the dips' is the preferred trading strategy. Hourly SMA 20 trend line is likely to provide a support from any pullbacks. The swing to upside will be significant considering the high positive sentiment forces (3.3). The extreme bullish overall sentiment (3) may signal the top of this uptrend. The sentiment for Broad Market Trend is calculated based on SPY trend. The sentiment for Sector Price Trend is calculated based on IBB trend. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Prefrence is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. |
| Date | Attention | Average Attention | Price | Price Level | Change | SMA10 Trend | Market Sentiment | Trend Sentiment | Fundamentals | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-17 | 0% | 0.3% | 165.26 | 96 | 0.65% | 0.5% | 1.4 | 1.2 | 1 | 8 |
| 2025-11-16 | 0% | 0.3% | 2.6 | 0.9 | 1.4 | 8 | ||||
| 2025-11-15 | 0% | 0.3% | 2.8 | 0.9 | 1.6 | 0 | ||||
| 2025-11-14 | 1% | 0.4% | 164.19 | 96 | 0.53% | 0.31% | 2.8 | 0.9 | 1.6 | 7.1 |
| 2025-11-13 | 0% | 0.3% | 163.32 | 95 | -0.99% | 0.38% | 2.8 | 0.5 | 1.7 | 7 |
| 2025-11-12 | 0% | 0.3% | 164.96 | 115 | 0.49% | 0.5% | 3 | 1.6 | 1.2 | 5 |
| 2025-11-11 | 1% | 0.4% | 164.15 | 123 | 2.91% | 0.38% | 3 | 1 | 1.5 | 4.5 |
| 2025-11-10 | 0% | 0.3% | 159.51 | 89 | 1.13% | 0.19% | 3.5 | 0.3 | 1 | 5 |
| 2025-11-09 | 0% | 0.4% | -0 | -0.3 | 0.9 | 0 | ||||
| 2025-11-08 | 1% | 0.4% | -0.2 | -0.3 | 0.6 | 6.7 | ||||
| Both emotion scores and sentiment scores are calculated in a -10 - +10 scale. | The price level reaches 100 at Bollinger upper band, and zero at lower band. |
| 1 (8) Deal With Eli Lilly Propels Founder Of Korean Biotech Firm Into Billionaire Ranks South Korea’s newest billionaire is Lee Sang-hoon, founder of ABL Bio, after it struck a $2.6 billion licensing and joint research deal with Eli Lilly. (https://www.forbes.com/) Mon. Nov 17, 2025 | |
| 2 (8) Maplebear, Tower Semiconductor, And Eli Lilly Are Among the Top 10 Large-Cap Gainers Last Week (Nov. 10-Nov. 14): Are the Others in Your Portfolio? Ten large-cap standouts—including Maplebear, Tower Semiconductor, Eli Lilly, On Holding, Albemarle, and key gold/silver miners—rallied last week on strong earnings, upbeat guidance, analyst upgrades, and expanded shareholder-return plans. (https://www.benzinga.com/) Sun. Nov 16, 2025 | |
About
Contact Us
Copyright ©2025 TheMarketUnfolds. All rights reserved. Denver, Colorado, USA